QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.068122v1 310/3/1046    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gao, Y. Articles by Brimijoin, S. Search for Related Content PubMed PubMed Citation Articles by Gao, Y. Articles by Brimijoin, S.

NEUROPHARMACOLOGY

An Engineered Cocaine Hydrolase Blunts and Reverses Cardiovascular Responses to Cocaine in Rats

Department of Molecular Pharmacology, Mayo Clinic, Rochester, Minnesota

There is increasing evidence that human plasma butyrylcholinesterase can lower the toxicity of cocaine overdose. Recently, with structure-based protein engineering, we converted this enzyme into a more efficient cocaine hydrolase (CocE). When tested in rats, CocE shortened cocaine's plasma half-life and decreased drug accumulation in heart and brain. Here, we have investigated the potential of CocE to antagonize cardiovascular responses to cocaine. Anesthetized rats were instrumented for continuous recording of blood pressure from the femoral artery. Cocaine (7 mg/kg i.v.) caused blood pressure to rise within 30 s by 25 to 37 mm Hg, but pressure returned to baseline within 60 s. These transient pressor responses were prolonged up to 5 min when vagal reflexes were blocked with atropine (1 mg/kg). Under such conditions, pretreatment with CocE (3 mg/kg i.v.) reduced cocaine's pressor effect, whereas delayed treatment with CocE rapidly restored normal mean blood pressure. CocE had no hemodynamic effects in control animals not treated with cocaine. The finding that CocE can oppose pre-established physiologic actions of cocaine suggests that similar or improved hydrolases might help rescue patients from the life-threatening toxicity of drug overdose.

Address correspondence to: Stephen Brimijoin, Department of Molecular Pharmacology, Mayo Clinic, 200 First Street S.W., Rochester MN 55905. E-mail: brimijoi{at}mayo.edu

This article has been cited by other articles:

				Z. D. Cooper, D. Narasimhan, R. K. Sunahara, P. Mierzejewski, E. M. Jutkiewicz, N. A. Larsen, I. A. Wilson, D. W. Landry, and J. H. Woods Rapid and Robust Protection against Cocaine-Induced Lethality in Rats by the Bacterial Cocaine Esterase Mol. Pharmacol., December 1, 2006; 70(6): 1885 - 1891. [Abstract] [Full Text] [PDF]

				Y. Gao, E. Atanasova, N. Sui, J. D. Pancook, J. D. Watkins, and S. Brimijoin Gene Transfer of Cocaine Hydrolase Suppresses Cardiovascular Responses to Cocaine in Rats Mol. Pharmacol., January 1, 2005; 67(1): 204 - 211. [Abstract] [Full Text] [PDF]